Prodia Diagnostic Line is trading 5.17% down at IDR 165.00; the October 12 catalyst remains unconfirmed.
- No company announcement or news dated October 12 was found that clearly explains the decline.
- The latest reported company-specific concern is older: first-half 2026 revenue fell 51.9% year over year, and the company recorded an IDR 8.84 billion net loss, attributed to product transition and shifted customer purchasing timing.
- The supplied market indices are flat, and available evidence does not establish that prior earnings pressure caused the move.